Android app Apple app link

UK-based Verdiva launches with $410m and an oral GLP-1RA candidate

By Yahoo! Finance   |   5 days ago
UK-based Verdiva launches with $410m and an oral GLP-1RA candidate

Verdiva Bio, a new biopharmaceutical company, focuses on obesity and cardiometabolic disorders with $410m in Series A funding. Led by experienced CEO Khurem Farooq, the company aims to develop innovative therapies for weight loss and maintenance.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.